News from NORD

CORD Offers Consensus Framework for Ethical Collaboration

Publish date: February 17, 2017

 

The Canadian Organization for Rare Disorders (CORD) has developed a Consensus Framework to encourage ethical collaboration among patient organizations, health care professionals, and the pharmaceutical industry.

Recommended Reading

PERSIST-2 might allay some concerns about pacritinib in myelofibrosis
MDedge Family Medicine
Adolescents, boys, black children most likely to be hospitalized in SJS and TEN
MDedge Family Medicine
AWaRDS Study Examines Services for Adults With Rare Disorders
MDedge Family Medicine
West Nile virus accounted for 95% of domestic arboviral disease in 2015
MDedge Family Medicine
Huntington’s Disease Society of America Publishes 2016 Research Report
MDedge Family Medicine
FDA approves Emflaza for Duchenne muscular dystrophy
MDedge Family Medicine
NORD Seeks Input Regarding Patient Protections and ACA
MDedge Family Medicine
Rare Disease Day 2017 Will Highlight Research Theme
MDedge Family Medicine
NORD to Partner Again With Hole in the Wall Gang Camp
MDedge Family Medicine
Apply Now to Join NORD’s Charity Marathon Team
MDedge Family Medicine